About Biodeal Pharmaceuticals
Biodeal Pharmaceuticals is a Healthcare company based in Delhi (India) founded in 2007 by Anurag Kumar. Pharmaceutical formulations are manufactured by Biodeal Pharmaceuticals in Delhi. Biodeal Pharmaceuticals has raised $13.2 million across 1 funding round from investors including Piramal Group. The company has 343 employees. Its Indian entity Biodeal Pharmaceuticals Limited reported revenue of ₹209 Cr. Biodeal Pharmaceuticals offers products and services including Domestic Pharmaceuticals, Nutraceuticals, Export Pharmaceuticals, and Derma and Cosmetics. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed competitors have raised funding.
Company details
Biodeal Pharmaceuticals was established in 2007 in Delhi, India, as a manufacturer of pharmaceutical formulations. Operations are centered on producing various drug formulations for the healthcare sector. The company is led by founder Anurag Kumar, serving as Managing Director. Activities are conducted from its base in Delhi, with a focus on standard pharmaceutical production processes. The domain biodealpharma.com is utilized for online presence.
- Headquarters Delhi, India
- Employees 343
- Founders Anurag Kumar
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biodealpharma.com
- Social LinkedIn X Facebook Instagram
- Legal Name Biodeal Pharmaceuticals Limited
- Date of Incorporation 30 Dec, 2005
- Jurisdiction Nalagarh, Distt. Solan (Hp), Himachal Pradesh, India
- Annual Revenue₹209 Cr
FY 2025 · +46% YoY
- Net Profit₹15.18 Cr
FY 2025 · 7% margin
- EBITDA₹45.28 Cr
FY 2025 · 22% margin
- Total Equity Funding$13.2M (USD)
in 1 rounds
- Latest Funding Round$13.2M (USD), Series B
Apr 2024
- Investors
- Employee Count343
Associated legal entities of Biodeal Pharmaceuticals
Biodeal Pharmaceuticals operates through Biodeal Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biodeal Pharmaceuticals Limited CIN U00304HP2005PLC029451 | Active | 30 Dec 2005 | Solan (Hp), Himachal Pradesh | ₹209 Cr | 343 | 9 | View details |
Products & Services of Biodeal Pharmaceuticals
Biodeal Pharmaceuticals offers a comprehensive portfolio of products and services, including Domestic Pharmaceuticals, Nutraceuticals, Export Pharmaceuticals, and Derma and Cosmetics.
Manufactures drugs for Indian market with quality standards.
Produces nutritional products for health and wellness.
Develops formulations for international markets.
Creates skin care products for consumer use.
Funding Insights of Biodeal Pharmaceuticals
Biodeal Pharmaceuticals has successfully raised a total of $13.2M through 1 strategic funding round. The most recent funding activity was a Series B round of $13.2 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.2M
- Total Rounds 1
- Last Round Series B — $13.2M
- First Round $13.2M
(Apr 2024)
- Investors Count 1
All 1 funding rounds of Biodeal Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $13.2M | Series B | – | – |
1 investors in total: 1 institutional.
Investors in Biodeal Pharmaceuticals
Biodeal Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Piramal Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | 1984 | piramal.com | Mumbai, India |
Investor details for Biodeal Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Biodeal Pharmaceuticals Limited (Biodeal Pharmaceuticals)
Biodeal Pharmaceuticals Limited is the primary company behind Biodeal Pharmaceuticals. The board of Biodeal Pharmaceuticals Limited currently have 6 directors; the longest-serving is Anurag Kumar, appointed in 2020. 20 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anurag Kumar DIN 08598700 | Managing Director | 31 Dec 2020 | 5 yrs 9 mo | Biodeal Pharmaceuticals Limited |
| Dev Datt DIN 09129131 | Director | 01 Apr 2021 | 5 yrs 6 mo | Biodeal Pharmaceuticals Limited |
| Anchal Kumari DIN 09804687 | Director | 30 Nov 2022 | 3 yrs 10 mo | Biodeal Pharmaceuticals Limited |
| Noopur Jha DIN 10620221 | Director | 14 Jun 2024 | 2 yrs 4 mo | Biodeal Pharmaceuticals Limited |
| Abhishek Jain DIN 10948377 | Nominee Director | 16 May 2025 | 1 yr 5 mo | Biodeal Pharmaceuticals Limited |
| Adheesh Chander Malhotra DIN 11144504 | Additional Director | 20 Jun 2025 | 1 yr 4 mo | Biodeal Pharmaceuticals Limited |
People of Biodeal Pharmaceuticals
2 people are tracked at Biodeal Pharmaceuticals (2 in leadership); the tracked headcount is 343.
| Name | Role | Group |
|---|---|---|
| Founder & Managing Director | Leadership | |
| Non-executive Director | Leadership |
Complete people profiles for Biodeal Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Biodeal Pharmaceuticals
Figures of Biodeal Pharmaceuticals Limited, the primary company behind Biodeal Pharmaceuticals, for FY 2025. Revenue was ₹209 Cr (+46% year on year). Net profit was ₹15.18 Cr (7% margin). EBITDA was ₹45.28 Cr (22% margin). Revenue has grown at a compounded annual rate of +43% over three years and +32% over five years.
- ₹209 CrRevenue · FY 2025 · +46% YoY
- ₹15.18 CrNet profit · 7% margin
- ₹45.28 CrEBITDA · 22% margin
- ₹25.34 CrPaid-up capital
- 343Employees (provident fund records)
- +43%Revenue CAGR, 3 years
- +32%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Biodeal Pharmaceuticals Limited are on its company page.
Detailed financial statements for Biodeal Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Biodeal Pharmaceuticals
2 dated milestones of Biodeal Pharmaceuticals across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Biodeal Pharmaceuticals is founded.
- Funding First funding round of $13.2M.
Competitors of Biodeal Pharmaceuticals
Biodeal Pharmaceuticals has 3 listed competitors in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed competitors of Biodeal Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biodeal Pharmaceuticals
The website of Biodeal Pharmaceuticals (biodealpharma.com) receives about 4.2K visits a month.
- Monthly visits4.2K
▼ 46.8% vs previous month
Websites whose visitors overlap most with Biodeal Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| zenerics.in | 100% | #1,668,321 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Biodeal Pharmaceuticals (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biodeal Pharmaceuticals
Complete news archive for Biodeal Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biodeal Pharmaceuticals
Biodeal Pharmaceuticals was founded in 2007 and raised its 1st funding round 17 years after it was founded.
Biodeal Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Biodeal Pharmaceuticals is a funded company, having raised a total of $13.2M across 1 funding round to date. The company's 1st funding round was a Series B of $13.2M, raised on Apr 2024.
Biodeal Pharmaceuticals has 343 employees.
The primary company behind Biodeal Pharmaceuticals, Biodeal Pharmaceuticals Limited, reported revenue of ₹209 Cr for FY 2025, up 46% year on year.
Biodeal Pharmaceuticals was established in 2007 in Delhi, India, as a manufacturer of pharmaceutical formulations. Operations are centered on producing various drug formulations for the healthcare sector. The company is led by founder Anurag Kumar, serving as Managing Director. Activities are conducted from its base in Delhi, with a focus on standard pharmaceutical production processes. The domain biodealpharma.com is utilized for online presence.
Biodeal Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Biodeal Pharmaceuticals offers Domestic Pharmaceuticals, Nutraceuticals, Export Pharmaceuticals, and Derma and Cosmetics.
Biodeal Pharmaceuticals has 1 investor. Key investors include Piramal Group.
Biodeal Pharmaceuticals operates through Biodeal Pharmaceuticals Limited.
The legal entities of Biodeal Pharmaceuticals currently have 9 directors, including Dev Datt, Anurag Kumar, Anchal Kumari and others.